Trade FBIOP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) is trading at US$18.14, down 0.27% today as of Sep 16, 11:46 EDT. Over the past 52 weeks, FBIOP has traded between US$6.27 and US$21.43. On Syfe you can trade FBIOP with $0 commission and add it to your watchlist.
| Previous close | US$18.19 |
|---|---|
| 52-week range | US$6.27 – US$21.43 |
| Volume | 7.32K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Year: 2017
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) stock is trading at US$18.14, -0.27% from the previous close of US$18.19.
The 52-week high for Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) stock is US$21.43.
The 52-week low for Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) stock is US$6.27.
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) does not currently pay a dividend.
Stay on top of FBIOP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
